Insufficient Data
Insufficient Data
Stock doesn't offer attractive dividend returns
Not a good time to invest, stock is in overbought zone
Stock in GSM list and too much promoter holding pledged
—
—
—
Parenteral Drugs (India) Limited is a healthcare company. The Company is engaged in the manufacturing of allopathic pharmaceutical preparations.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
PDPL : The Exchange had sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed. | Download
PDPL : The Exchange had sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed. | Download
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data